2025 annual financial data
Aquestive Therapeutics 2025 Operating margin
Direct answer
Operating margin was -156.36%.
Operating income was -69,650,279 USD and net income was -83,784,000 USD.
Operating cash flow was -52,432,000 USD.
Get free Aquestive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 44,545,000 USD
- Operating income
- -69,650,279 USD
- Net income
- -83,784,000 USD
- Operating cash flow
- -52,432,000 USD